The Risk of Pyelonephritis Following Uncomplicated Cystitis: A Nationwide Primary Healthcare Study

Background: The risk of pyelonephritis following uncomplicated lower urinary tract infection (cystitis) in women has not been studied in well-powered samples. This is likely due to the previous lack of nationwide primary healthcare data. We aimed to examine the risks of pyelonephritis following cyst...

Full description

Bibliographic Details
Main Authors: Filip Jansåker, Xinjun Li, Ingvild Vik, Niels Frimodt-Møller, Jenny Dahl Knudsen, Kristina Sundquist
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/11/12/1695
_version_ 1797461766083444736
author Filip Jansåker
Xinjun Li
Ingvild Vik
Niels Frimodt-Møller
Jenny Dahl Knudsen
Kristina Sundquist
author_facet Filip Jansåker
Xinjun Li
Ingvild Vik
Niels Frimodt-Møller
Jenny Dahl Knudsen
Kristina Sundquist
author_sort Filip Jansåker
collection DOAJ
description Background: The risk of pyelonephritis following uncomplicated lower urinary tract infection (cystitis) in women has not been studied in well-powered samples. This is likely due to the previous lack of nationwide primary healthcare data. We aimed to examine the risks of pyelonephritis following cystitis in women and explore if antibiotic treatment, cervical cancer, parity, and sociodemographic factors are related to these risks. Methods: This was a nationwide cohort study (2006–2018) of 752,289 women diagnosed with uncomplicated cystitis in primary healthcare settings. Of these, 404 696 did not redeem an antibiotic prescription within five days from cystitis. Logistic regression models were used to calculate odds ratios for pyelonephritis within 30 days and 90 days following the cystitis event. Results: Around one percent (7454) of all women with cystitis were diagnosed with pyelonephritis within 30 days, of which 78.2% had not redeemed an antibiotic for their cystitis. Antibiotic treatment was inversely associated with both outpatient registration and hospitalization due to pyelonephritis, with odds ratios of 0.85 (95% CI 0.80 to 0.91) and 0.65 (95% CI 0.55 to 0.77), respectively. Sociodemographic factors, parity, and cervical cancer were, with few exceptions (e.g., age and region of residency), not associated with pyelonephritis. Conclusions: Antibiotic treatment was inversely associated with pyelonephritis, but the absolute risk reduction was low. Non-antibiotic treatment for cystitis might be a safe option for most women. Future studies identifying the women at the highest risks will help clinicians in their decision making when treating cystitis, while keeping the ecological costs of antibiotics in mind.
first_indexed 2024-03-09T17:23:59Z
format Article
id doaj.art-661156466c5c469cad52a5c12b312d80
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-09T17:23:59Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-661156466c5c469cad52a5c12b312d802023-11-24T12:52:48ZengMDPI AGAntibiotics2079-63822022-11-011112169510.3390/antibiotics11121695The Risk of Pyelonephritis Following Uncomplicated Cystitis: A Nationwide Primary Healthcare StudyFilip Jansåker0Xinjun Li1Ingvild Vik2Niels Frimodt-Møller3Jenny Dahl Knudsen4Kristina Sundquist5Center for Primary Health Care Research, Department of Clinical Sciences Malmö, Lund University, 205 02 Malmö, SwedenCenter for Primary Health Care Research, Department of Clinical Sciences Malmö, Lund University, 205 02 Malmö, SwedenThe Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, 0318 Oslo, NorwayDepartment of Clinical Microbiology, Rigshospitalet, DK-2100 Copenhagen, DenmarkDepartment of Clinical Microbiology, Rigshospitalet, DK-2100 Copenhagen, DenmarkCenter for Primary Health Care Research, Department of Clinical Sciences Malmö, Lund University, 205 02 Malmö, SwedenBackground: The risk of pyelonephritis following uncomplicated lower urinary tract infection (cystitis) in women has not been studied in well-powered samples. This is likely due to the previous lack of nationwide primary healthcare data. We aimed to examine the risks of pyelonephritis following cystitis in women and explore if antibiotic treatment, cervical cancer, parity, and sociodemographic factors are related to these risks. Methods: This was a nationwide cohort study (2006–2018) of 752,289 women diagnosed with uncomplicated cystitis in primary healthcare settings. Of these, 404 696 did not redeem an antibiotic prescription within five days from cystitis. Logistic regression models were used to calculate odds ratios for pyelonephritis within 30 days and 90 days following the cystitis event. Results: Around one percent (7454) of all women with cystitis were diagnosed with pyelonephritis within 30 days, of which 78.2% had not redeemed an antibiotic for their cystitis. Antibiotic treatment was inversely associated with both outpatient registration and hospitalization due to pyelonephritis, with odds ratios of 0.85 (95% CI 0.80 to 0.91) and 0.65 (95% CI 0.55 to 0.77), respectively. Sociodemographic factors, parity, and cervical cancer were, with few exceptions (e.g., age and region of residency), not associated with pyelonephritis. Conclusions: Antibiotic treatment was inversely associated with pyelonephritis, but the absolute risk reduction was low. Non-antibiotic treatment for cystitis might be a safe option for most women. Future studies identifying the women at the highest risks will help clinicians in their decision making when treating cystitis, while keeping the ecological costs of antibiotics in mind.https://www.mdpi.com/2079-6382/11/12/1695antibioticscervical cancercomplicationscystitisparitypyelonephritis
spellingShingle Filip Jansåker
Xinjun Li
Ingvild Vik
Niels Frimodt-Møller
Jenny Dahl Knudsen
Kristina Sundquist
The Risk of Pyelonephritis Following Uncomplicated Cystitis: A Nationwide Primary Healthcare Study
Antibiotics
antibiotics
cervical cancer
complications
cystitis
parity
pyelonephritis
title The Risk of Pyelonephritis Following Uncomplicated Cystitis: A Nationwide Primary Healthcare Study
title_full The Risk of Pyelonephritis Following Uncomplicated Cystitis: A Nationwide Primary Healthcare Study
title_fullStr The Risk of Pyelonephritis Following Uncomplicated Cystitis: A Nationwide Primary Healthcare Study
title_full_unstemmed The Risk of Pyelonephritis Following Uncomplicated Cystitis: A Nationwide Primary Healthcare Study
title_short The Risk of Pyelonephritis Following Uncomplicated Cystitis: A Nationwide Primary Healthcare Study
title_sort risk of pyelonephritis following uncomplicated cystitis a nationwide primary healthcare study
topic antibiotics
cervical cancer
complications
cystitis
parity
pyelonephritis
url https://www.mdpi.com/2079-6382/11/12/1695
work_keys_str_mv AT filipjansaker theriskofpyelonephritisfollowinguncomplicatedcystitisanationwideprimaryhealthcarestudy
AT xinjunli theriskofpyelonephritisfollowinguncomplicatedcystitisanationwideprimaryhealthcarestudy
AT ingvildvik theriskofpyelonephritisfollowinguncomplicatedcystitisanationwideprimaryhealthcarestudy
AT nielsfrimodtmøller theriskofpyelonephritisfollowinguncomplicatedcystitisanationwideprimaryhealthcarestudy
AT jennydahlknudsen theriskofpyelonephritisfollowinguncomplicatedcystitisanationwideprimaryhealthcarestudy
AT kristinasundquist theriskofpyelonephritisfollowinguncomplicatedcystitisanationwideprimaryhealthcarestudy
AT filipjansaker riskofpyelonephritisfollowinguncomplicatedcystitisanationwideprimaryhealthcarestudy
AT xinjunli riskofpyelonephritisfollowinguncomplicatedcystitisanationwideprimaryhealthcarestudy
AT ingvildvik riskofpyelonephritisfollowinguncomplicatedcystitisanationwideprimaryhealthcarestudy
AT nielsfrimodtmøller riskofpyelonephritisfollowinguncomplicatedcystitisanationwideprimaryhealthcarestudy
AT jennydahlknudsen riskofpyelonephritisfollowinguncomplicatedcystitisanationwideprimaryhealthcarestudy
AT kristinasundquist riskofpyelonephritisfollowinguncomplicatedcystitisanationwideprimaryhealthcarestudy